nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CYP2E1—Dacarbazine—sarcoma	0.163	0.187	CbGbCtD
Ethosuximide—CYP2E1—Mitoxantrone—sarcoma	0.126	0.145	CbGbCtD
Ethosuximide—CYP3A7—Vincristine—sarcoma	0.09	0.103	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.09	0.103	CbGbCtD
Ethosuximide—CYP3A4—Thiotepa—sarcoma	0.089	0.102	CbGbCtD
Ethosuximide—CYP2E1—Etoposide—sarcoma	0.0796	0.0913	CbGbCtD
Ethosuximide—CYP3A5—Vincristine—sarcoma	0.0675	0.0774	CbGbCtD
Ethosuximide—CYP3A5—Etoposide—sarcoma	0.0619	0.0709	CbGbCtD
Ethosuximide—CYP3A4—Mitoxantrone—sarcoma	0.0383	0.0439	CbGbCtD
Ethosuximide—CYP3A4—Vincristine—sarcoma	0.0263	0.0302	CbGbCtD
Ethosuximide—CYP3A4—Etoposide—sarcoma	0.0241	0.0277	CbGbCtD
Ethosuximide—CYP3A4—Doxorubicin—sarcoma	0.0165	0.0189	CbGbCtD
Ethosuximide—Swollen tongue—Etoposide—sarcoma	0.00482	0.0377	CcSEcCtD
Ethosuximide—Vaginal haemorrhage—Thiotepa—sarcoma	0.00267	0.0209	CcSEcCtD
Ethosuximide—Aplastic anaemia—Dactinomycin—sarcoma	0.00184	0.0144	CcSEcCtD
Ethosuximide—Lethargy—Dactinomycin—sarcoma	0.00145	0.0113	CcSEcCtD
Ethosuximide—Ataxia—Thiotepa—sarcoma	0.00135	0.0105	CcSEcCtD
Ethosuximide—Ataxia—Vincristine—sarcoma	0.00119	0.00934	CcSEcCtD
Ethosuximide—Pancytopenia—Thiotepa—sarcoma	0.00118	0.0092	CcSEcCtD
Ethosuximide—Pancytopenia—Dactinomycin—sarcoma	0.00117	0.00913	CcSEcCtD
Ethosuximide—Abdominal pain upper—Mitoxantrone—sarcoma	0.00113	0.00884	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00109	0.0085	CcSEcCtD
Ethosuximide—Vaginal haemorrhage—Epirubicin—sarcoma	0.00107	0.0084	CcSEcCtD
Ethosuximide—Haematuria—Thiotepa—sarcoma	0.00105	0.00823	CcSEcCtD
Ethosuximide—Pancytopenia—Vincristine—sarcoma	0.00104	0.00816	CcSEcCtD
Ethosuximide—Rash erythematous—Epirubicin—sarcoma	0.00104	0.00812	CcSEcCtD
Ethosuximide—Agranulocytosis—Thiotepa—sarcoma	0.00103	0.00806	CcSEcCtD
Ethosuximide—Agranulocytosis—Dactinomycin—sarcoma	0.00102	0.008	CcSEcCtD
Ethosuximide—Pancytopenia—Mitoxantrone—sarcoma	0.00102	0.00794	CcSEcCtD
Ethosuximide—Vaginal haemorrhage—Doxorubicin—sarcoma	0.000993	0.00777	CcSEcCtD
Ethosuximide—Weight decreased—Vincristine—sarcoma	0.000993	0.00777	CcSEcCtD
Ethosuximide—Urinary tract disorder—Thiotepa—sarcoma	0.000979	0.00766	CcSEcCtD
Ethosuximide—Connective tissue disorder—Thiotepa—sarcoma	0.000974	0.00762	CcSEcCtD
Ethosuximide—Urethral disorder—Thiotepa—sarcoma	0.000971	0.0076	CcSEcCtD
Ethosuximide—Weight decreased—Mitoxantrone—sarcoma	0.000967	0.00757	CcSEcCtD
Ethosuximide—Rash erythematous—Doxorubicin—sarcoma	0.00096	0.00751	CcSEcCtD
Ethosuximide—Drowsiness—Mitoxantrone—sarcoma	0.000953	0.00746	CcSEcCtD
Ethosuximide—Erythema multiforme—Dactinomycin—sarcoma	0.00093	0.00727	CcSEcCtD
Ethosuximide—Cramp muscle—Etoposide—sarcoma	0.000927	0.00725	CcSEcCtD
Ethosuximide—Eye disorder—Thiotepa—sarcoma	0.000926	0.00724	CcSEcCtD
Ethosuximide—Haematuria—Mitoxantrone—sarcoma	0.000909	0.00711	CcSEcCtD
Ethosuximide—Immune system disorder—Thiotepa—sarcoma	0.000895	0.007	CcSEcCtD
Ethosuximide—Mediastinal disorder—Thiotepa—sarcoma	0.000893	0.00699	CcSEcCtD
Ethosuximide—Agranulocytosis—Mitoxantrone—sarcoma	0.00089	0.00696	CcSEcCtD
Ethosuximide—Mental disorder—Thiotepa—sarcoma	0.000868	0.00679	CcSEcCtD
Ethosuximide—Urinary tract disorder—Vincristine—sarcoma	0.000868	0.00679	CcSEcCtD
Ethosuximide—Connective tissue disorder—Vincristine—sarcoma	0.000863	0.00675	CcSEcCtD
Ethosuximide—Malnutrition—Thiotepa—sarcoma	0.000863	0.00675	CcSEcCtD
Ethosuximide—Urethral disorder—Vincristine—sarcoma	0.000861	0.00674	CcSEcCtD
Ethosuximide—Pancytopenia—Etoposide—sarcoma	0.000845	0.00661	CcSEcCtD
Ethosuximide—Hiccups—Epirubicin—sarcoma	0.000795	0.00622	CcSEcCtD
Ethosuximide—Agitation—Thiotepa—sarcoma	0.000793	0.0062	CcSEcCtD
Ethosuximide—Mediastinal disorder—Vincristine—sarcoma	0.000792	0.0062	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Etoposide—sarcoma	0.000786	0.00615	CcSEcCtD
Ethosuximide—Leukopenia—Thiotepa—sarcoma	0.000772	0.00604	CcSEcCtD
Ethosuximide—Mental disorder—Vincristine—sarcoma	0.00077	0.00602	CcSEcCtD
Ethosuximide—Leukopenia—Dactinomycin—sarcoma	0.000766	0.006	CcSEcCtD
Ethosuximide—Aplastic anaemia—Epirubicin—sarcoma	0.000746	0.00584	CcSEcCtD
Ethosuximide—Agranulocytosis—Etoposide—sarcoma	0.00074	0.00579	CcSEcCtD
Ethosuximide—Hiccups—Doxorubicin—sarcoma	0.000735	0.00575	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000729	0.00571	CcSEcCtD
Ethosuximide—Urinary tract disorder—Etoposide—sarcoma	0.000703	0.0055	CcSEcCtD
Ethosuximide—Agitation—Vincristine—sarcoma	0.000703	0.0055	CcSEcCtD
Ethosuximide—Urethral disorder—Etoposide—sarcoma	0.000698	0.00546	CcSEcCtD
Ethosuximide—Nervous system disorder—Thiotepa—sarcoma	0.00069	0.0054	CcSEcCtD
Ethosuximide—Aplastic anaemia—Doxorubicin—sarcoma	0.00069	0.0054	CcSEcCtD
Ethosuximide—Mental disability—Epirubicin—sarcoma	0.000689	0.00539	CcSEcCtD
Ethosuximide—Leukopenia—Vincristine—sarcoma	0.000685	0.00536	CcSEcCtD
Ethosuximide—Skin disorder—Thiotepa—sarcoma	0.000684	0.00535	CcSEcCtD
Ethosuximide—Erythema multiforme—Etoposide—sarcoma	0.000673	0.00526	CcSEcCtD
Ethosuximide—Anorexia—Thiotepa—sarcoma	0.000671	0.00525	CcSEcCtD
Ethosuximide—Leukopenia—Mitoxantrone—sarcoma	0.000667	0.00522	CcSEcCtD
Ethosuximide—Anorexia—Dactinomycin—sarcoma	0.000666	0.00521	CcSEcCtD
Ethosuximide—Eye disorder—Etoposide—sarcoma	0.000665	0.0052	CcSEcCtD
Ethosuximide—Immune system disorder—Etoposide—sarcoma	0.000643	0.00503	CcSEcCtD
Ethosuximide—Mediastinal disorder—Etoposide—sarcoma	0.000641	0.00502	CcSEcCtD
Ethosuximide—Mental disability—Doxorubicin—sarcoma	0.000638	0.00499	CcSEcCtD
Ethosuximide—Somnolence—Thiotepa—sarcoma	0.000626	0.0049	CcSEcCtD
Ethosuximide—Nervous system disorder—Vincristine—sarcoma	0.000612	0.00479	CcSEcCtD
Ethosuximide—Decreased appetite—Thiotepa—sarcoma	0.000612	0.00479	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Thiotepa—sarcoma	0.000608	0.00475	CcSEcCtD
Ethosuximide—Decreased appetite—Dactinomycin—sarcoma	0.000607	0.00475	CcSEcCtD
Ethosuximide—Fatigue—Thiotepa—sarcoma	0.000607	0.00475	CcSEcCtD
Ethosuximide—Fatigue—Dactinomycin—sarcoma	0.000602	0.00471	CcSEcCtD
Ethosuximide—Muscle spasms—Etoposide—sarcoma	0.000596	0.00466	CcSEcCtD
Ethosuximide—Anorexia—Vincristine—sarcoma	0.000595	0.00466	CcSEcCtD
Ethosuximide—Skin disorder—Mitoxantrone—sarcoma	0.000591	0.00462	CcSEcCtD
Ethosuximide—Lethargy—Epirubicin—sarcoma	0.000589	0.0046	CcSEcCtD
Ethosuximide—Anorexia—Mitoxantrone—sarcoma	0.00058	0.00453	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Thiotepa—sarcoma	0.000576	0.0045	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Dactinomycin—sarcoma	0.000571	0.00447	CcSEcCtD
Ethosuximide—Urticaria—Thiotepa—sarcoma	0.000559	0.00438	CcSEcCtD
Ethosuximide—Abdominal pain—Thiotepa—sarcoma	0.000557	0.00435	CcSEcCtD
Ethosuximide—Leukopenia—Etoposide—sarcoma	0.000555	0.00434	CcSEcCtD
Ethosuximide—Abdominal pain—Dactinomycin—sarcoma	0.000552	0.00432	CcSEcCtD
Ethosuximide—Lethargy—Doxorubicin—sarcoma	0.000545	0.00426	CcSEcCtD
Ethosuximide—Decreased appetite—Vincristine—sarcoma	0.000543	0.00425	CcSEcCtD
Ethosuximide—Ataxia—Epirubicin—sarcoma	0.000542	0.00424	CcSEcCtD
Ethosuximide—Somnolence—Mitoxantrone—sarcoma	0.00054	0.00423	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Vincristine—sarcoma	0.000539	0.00422	CcSEcCtD
Ethosuximide—Fatigue—Vincristine—sarcoma	0.000538	0.00421	CcSEcCtD
Ethosuximide—Decreased appetite—Mitoxantrone—sarcoma	0.000528	0.00413	CcSEcCtD
Ethosuximide—Abdominal pain upper—Epirubicin—sarcoma	0.000527	0.00412	CcSEcCtD
Ethosuximide—Fatigue—Mitoxantrone—sarcoma	0.000524	0.0041	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000524	0.0041	CcSEcCtD
Ethosuximide—Breast disorder—Epirubicin—sarcoma	0.000521	0.00408	CcSEcCtD
Ethosuximide—Hypersensitivity—Thiotepa—sarcoma	0.000519	0.00406	CcSEcCtD
Ethosuximide—Hypersensitivity—Dactinomycin—sarcoma	0.000515	0.00403	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Vincristine—sarcoma	0.00051	0.00399	CcSEcCtD
Ethosuximide—Asthenia—Thiotepa—sarcoma	0.000505	0.00395	CcSEcCtD
Ethosuximide—Ataxia—Doxorubicin—sarcoma	0.000502	0.00393	CcSEcCtD
Ethosuximide—Asthenia—Dactinomycin—sarcoma	0.000501	0.00392	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000497	0.00389	CcSEcCtD
Ethosuximide—Eosinophilia—Epirubicin—sarcoma	0.000494	0.00386	CcSEcCtD
Ethosuximide—Abdominal pain—Vincristine—sarcoma	0.000493	0.00386	CcSEcCtD
Ethosuximide—Skin disorder—Etoposide—sarcoma	0.000491	0.00384	CcSEcCtD
Ethosuximide—Abdominal pain upper—Doxorubicin—sarcoma	0.000487	0.00381	CcSEcCtD
Ethosuximide—Urticaria—Mitoxantrone—sarcoma	0.000483	0.00378	CcSEcCtD
Ethosuximide—Breast disorder—Doxorubicin—sarcoma	0.000482	0.00377	CcSEcCtD
Ethosuximide—Anorexia—Etoposide—sarcoma	0.000482	0.00377	CcSEcCtD
Ethosuximide—Diarrhoea—Thiotepa—sarcoma	0.000482	0.00377	CcSEcCtD
Ethosuximide—Abdominal pain—Mitoxantrone—sarcoma	0.000481	0.00376	CcSEcCtD
Ethosuximide—Diarrhoea—Dactinomycin—sarcoma	0.000478	0.00374	CcSEcCtD
Ethosuximide—Pancytopenia—Epirubicin—sarcoma	0.000473	0.0037	CcSEcCtD
Ethosuximide—Dizziness—Thiotepa—sarcoma	0.000466	0.00364	CcSEcCtD
Ethosuximide—Hypersensitivity—Vincristine—sarcoma	0.00046	0.0036	CcSEcCtD
Ethosuximide—Eosinophilia—Doxorubicin—sarcoma	0.000457	0.00357	CcSEcCtD
Ethosuximide—Weight decreased—Epirubicin—sarcoma	0.000451	0.00353	CcSEcCtD
Ethosuximide—Somnolence—Etoposide—sarcoma	0.00045	0.00352	CcSEcCtD
Ethosuximide—Hypersensitivity—Mitoxantrone—sarcoma	0.000448	0.0035	CcSEcCtD
Ethosuximide—Asthenia—Vincristine—sarcoma	0.000448	0.0035	CcSEcCtD
Ethosuximide—Vomiting—Thiotepa—sarcoma	0.000448	0.0035	CcSEcCtD
Ethosuximide—Drowsiness—Epirubicin—sarcoma	0.000444	0.00348	CcSEcCtD
Ethosuximide—Vomiting—Dactinomycin—sarcoma	0.000444	0.00348	CcSEcCtD
Ethosuximide—Rash—Thiotepa—sarcoma	0.000444	0.00347	CcSEcCtD
Ethosuximide—Dermatitis—Thiotepa—sarcoma	0.000443	0.00347	CcSEcCtD
Ethosuximide—Headache—Thiotepa—sarcoma	0.000441	0.00345	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000441	0.00345	CcSEcCtD
Ethosuximide—Rash—Dactinomycin—sarcoma	0.000441	0.00345	CcSEcCtD
Ethosuximide—Decreased appetite—Etoposide—sarcoma	0.00044	0.00344	CcSEcCtD
Ethosuximide—Pancytopenia—Doxorubicin—sarcoma	0.000438	0.00343	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Etoposide—sarcoma	0.000437	0.00342	CcSEcCtD
Ethosuximide—Asthenia—Mitoxantrone—sarcoma	0.000436	0.00341	CcSEcCtD
Ethosuximide—Fatigue—Etoposide—sarcoma	0.000436	0.00341	CcSEcCtD
Ethosuximide—Diarrhoea—Vincristine—sarcoma	0.000427	0.00334	CcSEcCtD
Ethosuximide—Haematuria—Epirubicin—sarcoma	0.000424	0.00332	CcSEcCtD
Ethosuximide—Nausea—Thiotepa—sarcoma	0.000418	0.00327	CcSEcCtD
Ethosuximide—Weight decreased—Doxorubicin—sarcoma	0.000417	0.00326	CcSEcCtD
Ethosuximide—Diarrhoea—Mitoxantrone—sarcoma	0.000416	0.00325	CcSEcCtD
Ethosuximide—Nausea—Dactinomycin—sarcoma	0.000415	0.00325	CcSEcCtD
Ethosuximide—Agranulocytosis—Epirubicin—sarcoma	0.000415	0.00324	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Etoposide—sarcoma	0.000414	0.00323	CcSEcCtD
Ethosuximide—Dizziness—Vincristine—sarcoma	0.000413	0.00323	CcSEcCtD
Ethosuximide—Drowsiness—Doxorubicin—sarcoma	0.000411	0.00322	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000408	0.00319	CcSEcCtD
Ethosuximide—Urticaria—Etoposide—sarcoma	0.000402	0.00314	CcSEcCtD
Ethosuximide—Abdominal pain—Etoposide—sarcoma	0.0004	0.00313	CcSEcCtD
Ethosuximide—Vomiting—Vincristine—sarcoma	0.000397	0.00311	CcSEcCtD
Ethosuximide—Urinary tract disorder—Epirubicin—sarcoma	0.000394	0.00308	CcSEcCtD
Ethosuximide—Rash—Vincristine—sarcoma	0.000394	0.00308	CcSEcCtD
Ethosuximide—Dermatitis—Vincristine—sarcoma	0.000393	0.00308	CcSEcCtD
Ethosuximide—Haematuria—Doxorubicin—sarcoma	0.000392	0.00307	CcSEcCtD
Ethosuximide—Connective tissue disorder—Epirubicin—sarcoma	0.000392	0.00307	CcSEcCtD
Ethosuximide—Urethral disorder—Epirubicin—sarcoma	0.000391	0.00306	CcSEcCtD
Ethosuximide—Headache—Vincristine—sarcoma	0.000391	0.00306	CcSEcCtD
Ethosuximide—Vomiting—Mitoxantrone—sarcoma	0.000387	0.00302	CcSEcCtD
Ethosuximide—Agranulocytosis—Doxorubicin—sarcoma	0.000384	0.003	CcSEcCtD
Ethosuximide—Rash—Mitoxantrone—sarcoma	0.000383	0.003	CcSEcCtD
Ethosuximide—Dermatitis—Mitoxantrone—sarcoma	0.000383	0.003	CcSEcCtD
Ethosuximide—Headache—Mitoxantrone—sarcoma	0.000381	0.00298	CcSEcCtD
Ethosuximide—Erythema multiforme—Epirubicin—sarcoma	0.000377	0.00295	CcSEcCtD
Ethosuximide—Eye disorder—Epirubicin—sarcoma	0.000373	0.00292	CcSEcCtD
Ethosuximide—Hypersensitivity—Etoposide—sarcoma	0.000373	0.00291	CcSEcCtD
Ethosuximide—Nausea—Vincristine—sarcoma	0.000371	0.0029	CcSEcCtD
Ethosuximide—Urinary tract disorder—Doxorubicin—sarcoma	0.000365	0.00285	CcSEcCtD
Ethosuximide—Asthenia—Etoposide—sarcoma	0.000363	0.00284	CcSEcCtD
Ethosuximide—Connective tissue disorder—Doxorubicin—sarcoma	0.000363	0.00284	CcSEcCtD
Ethosuximide—Urethral disorder—Doxorubicin—sarcoma	0.000362	0.00283	CcSEcCtD
Ethosuximide—Nausea—Mitoxantrone—sarcoma	0.000361	0.00283	CcSEcCtD
Ethosuximide—Immune system disorder—Epirubicin—sarcoma	0.00036	0.00282	CcSEcCtD
Ethosuximide—Mediastinal disorder—Epirubicin—sarcoma	0.00036	0.00281	CcSEcCtD
Ethosuximide—Mental disorder—Epirubicin—sarcoma	0.00035	0.00273	CcSEcCtD
Ethosuximide—Erythema multiforme—Doxorubicin—sarcoma	0.000349	0.00273	CcSEcCtD
Ethosuximide—Malnutrition—Epirubicin—sarcoma	0.000347	0.00272	CcSEcCtD
Ethosuximide—Diarrhoea—Etoposide—sarcoma	0.000346	0.00271	CcSEcCtD
Ethosuximide—Eye disorder—Doxorubicin—sarcoma	0.000345	0.0027	CcSEcCtD
Ethosuximide—Dizziness—Etoposide—sarcoma	0.000334	0.00262	CcSEcCtD
Ethosuximide—Muscle spasms—Epirubicin—sarcoma	0.000334	0.00261	CcSEcCtD
Ethosuximide—Immune system disorder—Doxorubicin—sarcoma	0.000333	0.00261	CcSEcCtD
Ethosuximide—Mediastinal disorder—Doxorubicin—sarcoma	0.000333	0.0026	CcSEcCtD
Ethosuximide—Mental disorder—Doxorubicin—sarcoma	0.000323	0.00253	CcSEcCtD
Ethosuximide—Vomiting—Etoposide—sarcoma	0.000322	0.00252	CcSEcCtD
Ethosuximide—Malnutrition—Doxorubicin—sarcoma	0.000321	0.00251	CcSEcCtD
Ethosuximide—Agitation—Epirubicin—sarcoma	0.000319	0.0025	CcSEcCtD
Ethosuximide—Rash—Etoposide—sarcoma	0.000319	0.00249	CcSEcCtD
Ethosuximide—Dermatitis—Etoposide—sarcoma	0.000319	0.00249	CcSEcCtD
Ethosuximide—Headache—Etoposide—sarcoma	0.000317	0.00248	CcSEcCtD
Ethosuximide—Leukopenia—Epirubicin—sarcoma	0.000311	0.00243	CcSEcCtD
Ethosuximide—Muscle spasms—Doxorubicin—sarcoma	0.000309	0.00242	CcSEcCtD
Ethosuximide—Nausea—Etoposide—sarcoma	0.0003	0.00235	CcSEcCtD
Ethosuximide—Agitation—Doxorubicin—sarcoma	0.000295	0.00231	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000294	0.0023	CcSEcCtD
Ethosuximide—Leukopenia—Doxorubicin—sarcoma	0.000288	0.00225	CcSEcCtD
Ethosuximide—Nervous system disorder—Epirubicin—sarcoma	0.000278	0.00217	CcSEcCtD
Ethosuximide—Skin disorder—Epirubicin—sarcoma	0.000275	0.00215	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000272	0.00213	CcSEcCtD
Ethosuximide—Anorexia—Epirubicin—sarcoma	0.00027	0.00211	CcSEcCtD
Ethosuximide—Nervous system disorder—Doxorubicin—sarcoma	0.000257	0.00201	CcSEcCtD
Ethosuximide—Skin disorder—Doxorubicin—sarcoma	0.000255	0.00199	CcSEcCtD
Ethosuximide—Somnolence—Epirubicin—sarcoma	0.000252	0.00197	CcSEcCtD
Ethosuximide—Anorexia—Doxorubicin—sarcoma	0.00025	0.00196	CcSEcCtD
Ethosuximide—Decreased appetite—Epirubicin—sarcoma	0.000246	0.00193	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Epirubicin—sarcoma	0.000245	0.00191	CcSEcCtD
Ethosuximide—Fatigue—Epirubicin—sarcoma	0.000244	0.00191	CcSEcCtD
Ethosuximide—Somnolence—Doxorubicin—sarcoma	0.000233	0.00182	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Epirubicin—sarcoma	0.000232	0.00181	CcSEcCtD
Ethosuximide—Decreased appetite—Doxorubicin—sarcoma	0.000228	0.00178	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000226	0.00177	CcSEcCtD
Ethosuximide—Fatigue—Doxorubicin—sarcoma	0.000226	0.00177	CcSEcCtD
Ethosuximide—Urticaria—Epirubicin—sarcoma	0.000225	0.00176	CcSEcCtD
Ethosuximide—Abdominal pain—Epirubicin—sarcoma	0.000224	0.00175	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Doxorubicin—sarcoma	0.000214	0.00168	CcSEcCtD
Ethosuximide—Hypersensitivity—Epirubicin—sarcoma	0.000209	0.00163	CcSEcCtD
Ethosuximide—Urticaria—Doxorubicin—sarcoma	0.000208	0.00163	CcSEcCtD
Ethosuximide—Abdominal pain—Doxorubicin—sarcoma	0.000207	0.00162	CcSEcCtD
Ethosuximide—Asthenia—Epirubicin—sarcoma	0.000203	0.00159	CcSEcCtD
Ethosuximide—Diarrhoea—Epirubicin—sarcoma	0.000194	0.00152	CcSEcCtD
Ethosuximide—Hypersensitivity—Doxorubicin—sarcoma	0.000193	0.00151	CcSEcCtD
Ethosuximide—Asthenia—Doxorubicin—sarcoma	0.000188	0.00147	CcSEcCtD
Ethosuximide—Dizziness—Epirubicin—sarcoma	0.000187	0.00147	CcSEcCtD
Ethosuximide—Vomiting—Epirubicin—sarcoma	0.00018	0.00141	CcSEcCtD
Ethosuximide—Diarrhoea—Doxorubicin—sarcoma	0.000179	0.0014	CcSEcCtD
Ethosuximide—Rash—Epirubicin—sarcoma	0.000179	0.0014	CcSEcCtD
Ethosuximide—Dermatitis—Epirubicin—sarcoma	0.000179	0.0014	CcSEcCtD
Ethosuximide—Headache—Epirubicin—sarcoma	0.000178	0.00139	CcSEcCtD
Ethosuximide—Dizziness—Doxorubicin—sarcoma	0.000173	0.00136	CcSEcCtD
Ethosuximide—Nausea—Epirubicin—sarcoma	0.000168	0.00132	CcSEcCtD
Ethosuximide—Vomiting—Doxorubicin—sarcoma	0.000167	0.0013	CcSEcCtD
Ethosuximide—Rash—Doxorubicin—sarcoma	0.000165	0.00129	CcSEcCtD
Ethosuximide—Dermatitis—Doxorubicin—sarcoma	0.000165	0.00129	CcSEcCtD
Ethosuximide—Headache—Doxorubicin—sarcoma	0.000164	0.00129	CcSEcCtD
Ethosuximide—Nausea—Doxorubicin—sarcoma	0.000156	0.00122	CcSEcCtD
